Project

Novel molecular intervention technology for infectious and allergic respiratory diseases

Code
01GC1412
Duration
01 January 2012 → 31 August 2018
Funding
Regional and community funding: Special Research Fund
Research disciplines
  • Natural sciences
    • Microbiology not elsewhere classified
    • Systems biology not elsewhere classified
  • Medical and health sciences
    • Immunology not elsewhere classified
    • Laboratory medicine not elsewhere classified
    • Microbiology not elsewhere classified
    • Vaccinology
    • Laboratory medicine not elsewhere classified
    • Microbiology not elsewhere classified
    • Vaccinology
    • Laboratory medicine not elsewhere classified
    • Microbiology not elsewhere classified
Keywords
respiratory diseases vaccination BCG tuberculosis influenza cytokines siRNA T lymphocytes
 
Project description

This collaborative interfaculty project aims at the development of novel

therapeutic approaches for the treatment of infectious and allergic

respiratory diseases and the elucidation of the underlying mechanisms. Animal

models of Mycobacterium tuberculosis and Influenza infection along with models

for mild to severe asthma will be combined with modified vaccinogens, immune

interference and in situ siRNA delivery.